Financials & Filings Investors Investor Relations Overview Press Releases Events & Presentations Corporate Governance Financials & Filings SEC Filings Annual Reports Quarterly Results Key Ratios Stock Information Investor FAQs Contact Us Financials & Filings First Quarter Financial Results Show all 2023 First Quarter Arrowhead Pharmaceuticals 2023 First Quarter Results Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results Form 10-Q Proxy Statements Filing date View Dec 27, 2004 0001193125-04-219691.pdf 0001193125-04-219691.rtf 0001193125-04-219691.xls View HTML Jan 18, 2006 0001193125-06-007406.pdf 0001193125-06-007406.rtf 0001193125-06-007406.xls View HTML Form 10-K Filing date View Dec 14, 2006 View HTML 0001193125-06-253375.pdf 0001193125-06-253375.rtf 0001193125-06-253375.xls Dec 14, 2007 View HTML 0001193125-07-265636.pdf 0001193125-07-265636.rtf 0001193125-07-265636.xls Form 10-Q Filing date View Feb 11, 1998 0000879407-98-000003.pdf 0000879407-98-000003.rtf View HTML May 13, 1998 0000879407-98-000005.pdf 0000879407-98-000005.rtf View HTML
Financials & Filings First Quarter Financial Results Show all 2023 First Quarter Arrowhead Pharmaceuticals 2023 First Quarter Results Arrowhead Pharmaceuticals Reports Fiscal 2023 First Quarter Results Form 10-Q Proxy Statements Filing date View Dec 27, 2004 0001193125-04-219691.pdf 0001193125-04-219691.rtf 0001193125-04-219691.xls View HTML Jan 18, 2006 0001193125-06-007406.pdf 0001193125-06-007406.rtf 0001193125-06-007406.xls View HTML Form 10-K Filing date View Dec 14, 2006 View HTML 0001193125-06-253375.pdf 0001193125-06-253375.rtf 0001193125-06-253375.xls Dec 14, 2007 View HTML 0001193125-07-265636.pdf 0001193125-07-265636.rtf 0001193125-07-265636.xls Form 10-Q Filing date View Feb 11, 1998 0000879407-98-000003.pdf 0000879407-98-000003.rtf View HTML May 13, 1998 0000879407-98-000005.pdf 0000879407-98-000005.rtf View HTML